Publications
Specialty
Search
EMSWorld, Emergency & Mobile Medicine
10/18/2024
Let’s shed those sacred cows and embrace a new era of EMS—one where expertise and efficiency drive our success.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
10/18/2024
“We commend the AMA’s issuance of this upgraded Category I CPT billing code, which validates the technology’s clinical value in quantifying and characterizing plaque to help assess risk and personalize treatment for patients with coronary artery disease,” said Campbell Rogers, MD, FACC.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
10/18/2024
“Young Middle Eastern women who are obese or overweight are facing a higher risk for the development of atherosclerotic cardiovascular disease and its associated risk factors like hypertension and Type Two diabetes,” said Mohammad Adnan Bani Baker, MD, a medical doctor at Prince Hamza Hospital in Amman, Jordan.
Lymphoma, Leukemia & Myeloma Network, Oncology
10/18/2024
At the 2024 Lymphoma, Leukemia & Myeloma Congress, Joanna Rhodes, MD, participated in a debate in which she discussed the use of novel therapies including targeted agents for treating patients with relapsed/refractory follicular lymphoma.
EMSWorld, Emergency & Mobile Medicine
10/18/2024
Jon Krohmer on proposed CMS modifications to reimbursement for whole blood delivery; Jeffrey Goodloe on the fiscal impact of hospital bed delays on EMS systems; Aileen Marty on long COVID research; and more.
EMSWorld, Emergency & Mobile Medicine
10/18/2024
Aileen Marty on monkeypox; Crawford Mechem on the latest opioid challenges in Philadelphia; Paul Pepe on whole blood delivery in Texas; Gam Wijetunge on what's new at NHTSA; and more.
Rheumatology & Arthritis
10/18/2024
More study is needed to gain understanding of how physical work may influence disease activity among patients with psoriatic arthritis.
EMS World Américas
10/18/2024
Estos días, la administración prehospitalaria de ketamina es un tema candente.
Rheumatology & Arthritis
10/18/2024
Clinicians should be mindful of potential surprise findings on imaging that may necessitate changes in treatment.
The Dermatologist
10/18/2024
What were the primary findings regarding the long-term safety of risankizumab?
Rheumatology & Arthritis
10/18/2024
The findings of a recent study suggest that menopause, particularly early menopause, may increase the risk of developing rheumatoid arthritis in women.
Rheumatology & Arthritis
10/18/2024
Nonadherence to receiving hydroxychloroquine is associated with a 3-fold higher risk of lupus-related hospitalization.
Rheumatology & Arthritis
10/18/2024
Researchers aimed to explore risk factors associated with usual interstitial pneumonia and nonspecific interstitial pneumonia.
Rheumatology & Arthritis
10/18/2024
Pain and swelling result in difficulty with daily activities and tasks, according to survey results.
Gastroenterology
10/18/2024
Upper gastrointestinal (GI) mucosal damage was associated with elevated risk of developing Parkinson's disease.
Gastroenterology
10/18/2024
Vonoprazan offers an effective alternative treatment to intravenous proton pump inhibitors for prevention of rebleeding among patients with high-risk peptic ulcers, researchers found.
Oncology
10/18/2024
Results from the phase 2 ABIGAIL trial demonstrated that first-line abemaciclib plus endocrine therapy improves efficacy compared to standard chemotherapy among patients with HR-positive, HER2-negative advanced breast cancer.
Gastroenterology
10/18/2024
New nomenclature shows strong applicability in real-world clinical settings.
First Report Managed Care
10/18/2024
Peripheral residual disease identified using next-generation flow in patients with transplant-eligible multiple myeloma was associated with a 13-fold increased risk of progression or death, according to a clinical trial update published online ahead of print in the Journal of Clinical Oncology.
Gastroenterology
10/18/2024
Results showed that a lower fibrosis stage (F0–1) was associated with a significantly reduced risk of cirrhosis and liver-related outcomes compared to patients with advanced fibrosis (F4).